Logo image of IQV

IQVIA HOLDINGS INC (IQV) Stock Fundamental Analysis

NYSE:IQV - New York Stock Exchange, Inc. - US46266C1053 - Common Stock - Currency: USD

191.04  -2.97 (-1.53%)

After market: 191.04 0 (0%)

Fundamental Rating

4

IQV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. IQV scores excellent on profitability, but there are concerns on its financial health. IQV has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year IQV was profitable.
IQV had a positive operating cash flow in the past year.
IQV had positive earnings in 4 of the past 5 years.
IQV had a positive operating cash flow in 4 of the past 5 years.
IQV Yearly Net Income VS EBIT VS OCF VS FCFIQV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

1.2 Ratios

With an excellent Return On Assets value of 5.17%, IQV belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
The Return On Equity of IQV (20.17%) is better than 94.74% of its industry peers.
IQV has a better Return On Invested Capital (9.33%) than 91.23% of its industry peers.
IQV had an Average Return On Invested Capital over the past 3 years of 7.75%. This is in line with the industry average of 9.61%.
The 3 year average ROIC (7.75%) for IQV is below the current ROIC(9.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.17%
ROE 20.17%
ROIC 9.33%
ROA(3y)4.44%
ROA(5y)3.05%
ROE(3y)19.04%
ROE(5y)12.99%
ROIC(3y)7.75%
ROIC(5y)6.1%
IQV Yearly ROA, ROE, ROICIQV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

1.3 Margins

IQV's Profit Margin of 9.17% is fine compared to the rest of the industry. IQV outperforms 78.95% of its industry peers.
IQV's Profit Margin has improved in the last couple of years.
IQV has a better Operating Margin (14.14%) than 77.19% of its industry peers.
In the last couple of years the Operating Margin of IQV has grown nicely.
Looking at the Gross Margin, with a value of 35.17%, IQV is doing worse than 63.16% of the companies in the same industry.
IQV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.14%
PM (TTM) 9.17%
GM 35.17%
OM growth 3Y25.9%
OM growth 5Y12.1%
PM growth 3Y54.53%
PM growth 5Y29.51%
GM growth 3Y0.96%
GM growth 5Y-0.14%
IQV Yearly Profit, Operating, Gross MarginsIQV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IQV is destroying value.
IQV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IQV Yearly Shares OutstandingIQV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
IQV Yearly Total Debt VS Total AssetsIQV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 2.07 indicates that IQV is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.07, IQV perfoms like the industry average, outperforming 56.14% of the companies in the same industry.
The Debt to FCF ratio of IQV is 6.89, which is on the high side as it means it would take IQV, 6.89 years of fcf income to pay off all of its debts.
IQV has a Debt to FCF ratio of 6.89. This is in the better half of the industry: IQV outperforms 61.40% of its industry peers.
IQV has a Debt/Equity ratio of 1.76. This is a high value indicating a heavy dependency on external financing.
IQV's Debt to Equity ratio of 1.76 is on the low side compared to the rest of the industry. IQV is outperformed by 82.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF 6.89
Altman-Z 2.07
ROIC/WACC0.86
WACC10.89%
IQV Yearly LT Debt VS Equity VS FCFIQV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B 10B

2.3 Liquidity

IQV has a Current Ratio of 0.81. This is a bad value and indicates that IQV is not financially healthy enough and could expect problems in meeting its short term obligations.
IQV's Current ratio of 0.81 is on the low side compared to the rest of the industry. IQV is outperformed by 91.23% of its industry peers.
A Quick Ratio of 0.81 indicates that IQV may have some problems paying its short term obligations.
With a Quick ratio value of 0.81, IQV is not doing good in the industry: 85.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.81
IQV Yearly Current Assets VS Current LiabilitesIQV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.11% over the past year.
The Earnings Per Share has been growing by 11.72% on average over the past years. This is quite good.
EPS 1Y (TTM)9.11%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%9.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.33%

3.2 Future

Based on estimates for the next years, IQV will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.66% on average per year.
Based on estimates for the next years, IQV will show a small growth in Revenue. The Revenue will grow by 6.46% on average per year.
EPS Next Y7.7%
EPS Next 2Y9.63%
EPS Next 3Y9.99%
EPS Next 5Y10.66%
Revenue Next Year4.31%
Revenue Next 2Y5.17%
Revenue Next 3Y5.56%
Revenue Next 5Y6.46%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
IQV Yearly Revenue VS EstimatesIQV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
IQV Yearly EPS VS EstimatesIQV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.15, which indicates a rather expensive current valuation of IQV.
96.49% of the companies in the same industry are more expensive than IQV, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 30.30, IQV is valued a bit cheaper.
With a Price/Forward Earnings ratio of 15.92, IQV is valued correctly.
94.74% of the companies in the same industry are more expensive than IQV, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.06. IQV is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.15
Fwd PE 15.92
IQV Price Earnings VS Forward Price EarningsIQV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

IQV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IQV is cheaper than 92.98% of the companies in the same industry.
IQV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IQV is cheaper than 91.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.16
EV/EBITDA 13.92
IQV Per share dataIQV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
IQV has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.23
PEG (5Y)1.46
EPS Next 2Y9.63%
EPS Next 3Y9.99%

More info and screens

0

5. Dividend

5.1 Amount

IQV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IQVIA HOLDINGS INC

NYSE:IQV (2/21/2025, 4:34:48 PM)

After market: 191.04 0 (0%)

191.04

-2.97 (-1.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)04-30 2025-04-30/bmo
Inst Owners94.46%
Inst Owner Change-1.23%
Ins Owners0.89%
Ins Owner Change1.14%
Market Cap33.64B
Analysts81.29
Price Target253.18 (32.53%)
Short Float %1.68%
Short Ratio2.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.98%
Min EPS beat(2)0.06%
Max EPS beat(2)1.9%
EPS beat(4)3
Avg EPS beat(4)0.76%
Min EPS beat(4)-0.32%
Max EPS beat(4)1.9%
EPS beat(8)6
Avg EPS beat(8)0.72%
EPS beat(12)10
Avg EPS beat(12)1.25%
EPS beat(16)14
Avg EPS beat(16)2.41%
Revenue beat(2)0
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-0.34%
Max Revenue beat(2)0%
Revenue beat(4)1
Avg Revenue beat(4)0.11%
Min Revenue beat(4)-0.34%
Max Revenue beat(4)0.89%
Revenue beat(8)2
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.22%
Revenue beat(16)8
Avg Revenue beat(16)0.73%
PT rev (1m)-0.21%
PT rev (3m)-8.52%
EPS NQ rev (1m)0.21%
EPS NQ rev (3m)-0.01%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-0.04%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.02%
Valuation
Industry RankSector Rank
PE 17.15
Fwd PE 15.92
P/S 2.2
P/FCF 17.16
P/OCF 13.05
P/B 4.83
P/tB N/A
EV/EBITDA 13.92
EPS(TTM)11.14
EY5.83%
EPS(NY)12
Fwd EY6.28%
FCF(TTM)11.14
FCFY5.83%
OCF(TTM)14.64
OCFY7.66%
SpS86.97
BVpS39.56
TBVpS-73.02
PEG (NY)2.23
PEG (5Y)1.46
Profitability
Industry RankSector Rank
ROA 5.17%
ROE 20.17%
ROCE 10.72%
ROIC 9.33%
ROICexc 10.19%
ROICexgc N/A
OM 14.14%
PM (TTM) 9.17%
GM 35.17%
FCFM 12.8%
ROA(3y)4.44%
ROA(5y)3.05%
ROE(3y)19.04%
ROE(5y)12.99%
ROIC(3y)7.75%
ROIC(5y)6.1%
ROICexc(3y)8.35%
ROICexc(5y)6.57%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.91%
ROCE(5y)7.01%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y36.6%
ROICexc growth 5Y19.76%
OM growth 3Y25.9%
OM growth 5Y12.1%
PM growth 3Y54.53%
PM growth 5Y29.51%
GM growth 3Y0.96%
GM growth 5Y-0.14%
F-Score8
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF 6.89
Debt/EBITDA 3.73
Cap/Depr 54.75%
Cap/Sales 4.03%
Interest Coverage 250
Cash Conversion 78.31%
Profit Quality 139.57%
Current Ratio 0.81
Quick Ratio 0.81
Altman-Z 2.07
F-Score8
WACC10.89%
ROIC/WACC0.86
Cap/Depr(3y)55.99%
Cap/Depr(5y)52.85%
Cap/Sales(3y)4.54%
Cap/Sales(5y)4.86%
Profit Quality(3y)164.71%
Profit Quality(5y)282.53%
High Growth Momentum
Growth
EPS 1Y (TTM)9.11%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%9.86%
EPS Next Y7.7%
EPS Next 2Y9.63%
EPS Next 3Y9.99%
EPS Next 5Y10.66%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.33%
Revenue Next Year4.31%
Revenue Next 2Y5.17%
Revenue Next 3Y5.56%
Revenue Next 5Y6.46%
EBIT growth 1Y11.89%
EBIT growth 3Y38.07%
EBIT growth 5Y20.57%
EBIT Next Year23.11%
EBIT Next 3Y11.38%
EBIT Next 5Y9.96%
FCF growth 1Y15.01%
FCF growth 3Y3.75%
FCF growth 5Y13.54%
OCF growth 1Y7.78%
OCF growth 3Y3.13%
OCF growth 5Y11.38%